InsidersTradesSigma
Discover the complete record of transactions filed by Zhang Jack Y., Chief Executive Officer. Officer active across 1 companies, notably Amphastar Pharmaceuticals, Inc.. Aggregated, 5 disclosures have been logged. Total volume traded: €4m. The latest transaction was filed on 20 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Jack Y. Zhang is the CEO & Chief Scientific Officer at Amphastar Pharmaceuticals, Inc. He is responsible for the strategic leadership and scientific initiatives of the company. With expertise in the pharmaceutical sector, Jack Y. Zhang plays a key role in developing new therapies and optimizing research processes. His commitment to innovation and research is essential for Amphastar's success.